Windtree Therapeutics, Inc. (WINT) Ownership
WINT ownership summary
as of October 21, 2026- Institutions
- 0.0% of shares outstanding
- Insiders
- 0.00% of shares outstanding
- Shares outstanding
- 33.7M
- Float
- 33.7M shares available to trade
- Short interest
- 3.96% 1.8M shares short
- Days to cover
- 0.09 short interest down 31.2% vs prior month
- Other investors 100.00%
WINT top institutional holders
1 largest| # | Holder | % of shares | Shares | Value | Change | Reported |
|---|---|---|---|---|---|---|
| 1 | Urban Wealth Management, LLC | 0.00% | — | — | — | December 31, 2025 |
Value at the latest close. Change = shares bought or sold in the latest quarterly filing (13F). In the top 1, 0 holders added 0 shares and 0 cut 0.
WINT top mutual fund and ETF holders
1 largest| # | Holder | % of shares | Shares | Value | Change | Reported |
|---|---|---|---|---|---|---|
| 1 | Blackstone Alternative Multi-Strategy I | <0.01% | 38 | $0 | +38 (0.0%) | June 30, 2025 |
Funds report holdings monthly or quarterly; dates differ by fund.
WINT insider transactions
latest 2| Date | Name | Transaction | Price | Shares | Value |
|---|---|---|---|---|---|
| 2024-10-08 | Craig Fraser | Buy | $45.50 | 108 | $4,914 |
| 2023-09-26 | Craig Fraser | Buy | $810.00 | 2 | $1,620 |
Reported trades by company officers, directors and other filers (including disclosures by members of Congress where EODHD lists them). "—" where the filing gives no share count.
WINT shares outstanding
Year-end shares outstanding, adjusted for splits.
Who owns WINT
Institutional investors own 0.0% of Windtree Therapeutics's shares and insiders 0.00%. The largest holder is Urban Wealth Management, LLC with 0.00% of the shares (0), as of December 31, 2025. Among the top 1 institutions, 0 added shares and 0 reduced their stake in the latest filings. Short interest is 3.96% of the float, or 0.09 days of average trading volume. The share count rose 888.9% since 2015.
Related: WINT analyst forecast, WINT key metrics. See the WINT stock overview for the latest quote and news.
WINT ownership FAQ
Who owns the most Windtree Therapeutics stock?
The largest shareholders of Windtree Therapeutics are Urban Wealth Management, LLC (0.00%).
What percentage of Windtree Therapeutics is owned by institutions?
Institutions hold 0.0% of Windtree Therapeutics's shares outstanding; insiders hold 0.00%.
Which funds own Windtree Therapeutics?
The largest fund holders of Windtree Therapeutics are Blackstone Alternative Multi-Strategy I (<0.01%).
What is Windtree Therapeutics's short interest?
1.8M shares of Windtree Therapeutics were sold short, 3.96% of the float; at the average daily volume it would take 0.09 days to cover.
Are insiders buying or selling Windtree Therapeutics?
Of the latest 2 reported insider transactions in Windtree Therapeutics (since September 26, 2023), 2 were purchases and 0 were sales.
How many shares of Windtree Therapeutics are outstanding?
Windtree Therapeutics has 33.7M shares outstanding, of which 33.7M are in the public float.